August 26, 2022
Trending story 
Paxlovid, the COVID-19 antiviral pill developed by Pfizer that was once celebrated as a "game-changer" for the pandemic, has little to no benefit for younger adults, while it still appears to reduce the risk of hospitalization or death for high-risk seniors, according to a new study published Wednesday. “Among patients 65 years of age or older, the ... Read more
More stories for you
© 2022 Blaze Media LLC. All Rights Reserved. You are receiving this email because you opted in to receive emails from Blaze Media. Privacy Policy | Manage your preferences | Unsubscribe 8275 S. Eastern Ave, Ste 200-245 Las Vegas, Nevada, 89123, USA
|
